(Q84024491)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19506882%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

title

Third generation anti-cyclic citrullinated peptide antibodies do not predict anti-TNF-alpha treatment response in rheumatoid arthritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19506882%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19506882%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Werner Klotz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19506882%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Michael Schirmer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19506882%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

author name string

Christina Duftner

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19506882%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Manfred Herold

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19506882%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

publication date

9 June 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19506882%20AND%20SRC:MED&resulttype=core&format=json

Rheumatology International

30 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19506882%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19506882%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19506882%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

451-454

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19506882%20AND%20SRC:MED&resulttype=core&format=json

Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study

30 January 2020

cites work

1 reference

12 December 2020

Vimentin is secreted by activated macrophages

1 reference

12 December 2020

A comparative study of IgG second- and third-generation anti-cyclic citrullinated peptide (CCP) ELISAs and their combination with IgA third-generation CCP ELISA for the diagnosis of rheumatoid arthritis

1 reference

12 December 2020

Predictive value of antibodies to citrullinated peptides and rheumatoid factors in anti-TNF-alpha treated patients

1 reference

12 December 2020

Autoimmunity and anti-TNF-alpha agents

1 reference

12 December 2020

Antibodies against mutated citrullinated vimentin fail to predict anti-TNFalpha treatment response in rheumatoid arthritis

1 reference

12 December 2020

Comparison of second- and third-generation anti-cyclic citrullinated peptide antibodies assays for detecting rheumatoid arthritis

1 reference

12 December 2020

Diagnostic usefulness of a third-generation anti-cyclic citrulline antibody test in patients with recent-onset polyarthritis

1 reference

12 December 2020

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumati

1 reference

12 December 2020

The efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomised controlled trials and clinical practice

1 reference

12 December 2020

High IgA rheumatoid factor levels are associated with poor clinical response to tumour necrosis factor alpha inhibitors in rheumatoid arthritis

1 reference

12 December 2020